NVAX | Novavax, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	8.37 - 8.89
52 Week Range	3.53 - 23.86
Beta	1.92
Implied Volatility	161.26%
IV Rank	55.22%
Day's Volume	5,452,396
Average Volume	5,708,849
Shares Outstanding	160,185,000
Market Cap	1,393,609,500
Sector	Healthcare
Industry	Biotechnology
IPO Date	1995-12-05

Valuation
Profitability
Growth
Health
P/E Ratio	-3.99
Forward P/E Ratio	N/A
EPS	-2.18
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	1,543
Country	USA
Website	NVAX

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

NVAX's peers: ANVS, ATOS, AVXL, BNTX, CYCCP, INO, MRNA, VXRT, AZN, NVO, OCGN, TNXP, VERU

*Chart delayed

Analyzing fundamentals for NVAX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is poor, Growth is good and Health is frighteningly weak. For more detailed analysis please see NVAX Fundamentals page.

Watching at NVAX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on NVAX Technicals page.